Resultados de la búsqueda 251-260 of 10047 for Cycle

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    On the second part of this study, patients will receive the remainder of the chemotherapy cycles (interim maintenance I, delayed intensification, interim ...

  2. Sangrado vaginal Causas - Mayo Clinic

    Your menstrual cycle. Office on Women's Health. https://www.womenshealth.gov/menstrual-cycle/your-menstrual-cycle. Accessed Jan. 24, 2023. Goodman A ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All participants who have completed the first course of pembrolizumab may be eligible for up to an additional 9 cycles of pembrolizumab monotherapy if there ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All participants who have completed the first course of pembrolizumab may be eligible for up to an additional 9 cycles of pembrolizumab monotherapy if there ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All participants who have completed the first course of pembrolizumab may be eligible for up to an additional 9 cycles of pembrolizumab monotherapy if there ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... cycles (R-CHOP-21) and CC99282 in combination with R-CHOP-21 in subjects with previously untreated, high risk (International Prognostic Index [IPI] 3 to 5) ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... cycles (R-CHOP-21) and CC99282 in combination with R-CHOP-21 in subjects with previously untreated, high risk (International Prognostic Index [IPI] 3 to 5) ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    On the second part of this study, patients will receive the remainder of the chemotherapy cycles (interim maintenance I, delayed intensification, interim ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... cycles of mosunetuzumab. An additional arm (open to non-US participants only) has been added to assess the safety, tolerability, pharmacokinetics, and ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... cycles of mosunetuzumab. An additional arm (open to non-US participants only) has been added to assess the safety, tolerability, pharmacokinetics, and ...